Effect of a β-TCP collagen composite bone substitute on healing of drilled bone voids in the distal femoral condyle of rabbits

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 102, Issue 2, 2014, Pages 376-383

  Zheng, Hellen ^a   Bai, Yajun ^a   Shih, Mei Shu ^a   Hoffmann, Christiane ^b   Peters, Fabian ^b   Waldner, Christoph ^b   Hübner, Wolf Dietrich ^b  

^a PharmaLegacy Laboratories   (China)

^b Curasan AG   (Germany)

Author keywords

TCP; bone void; femoral defect; rabbits

Indexed keywords

BIOMECHANICAL EVALUATION; COLLAGEN COMPOSITES; CRITICAL SIZE DEFECT; FEMORAL DEFECTS; FOREIGN BODY REACTIONS; RABBITS; SURGICAL APPLICATIONS; TRI-CALCIUM PHOSPHATES;

ANIMALS; BIOCOMPATIBILITY; COLLAGEN; FOAMS; IMPLANTS (SURGICAL); QUALITY CONTROL; TRANSMISSION CONTROL PROTOCOL;

BONE;

CALCIUM PHOSPHATE; COLLAGEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE FILLER; BONE PROSTHESIS; COMPOSITE MATERIAL; CONTROLLED STUDY; FEMUR CONDYLE; FRACTURE HEALING; MALE; MORPHOMETRICS; NONHUMAN; RABBIT;

BONE VOID; FEMORAL DEFECT; RABBITS; Β-TCP;

ANIMALS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; COLLAGEN; FEMUR HEAD; MALE; MATERIALS TESTING; RABBITS; WOUND HEALING;

EID: 84892434257     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33016     Document Type: Article

References (35)

1. Heary RF, Schlenk RP, Sacchieri TA, Barone D, Brotea C,. Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery 2002; 50: 510-516.
2. Silber JS, Anderson DG, Daffner SD, Brislin BT, Leland JM, Hilibrand AS, Vaccaro AR, Albert TJ,. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine (Phila Pa 1976.) 2003; 28: 134-139.
3. Tomford WW,. Bone allografts: past, present and future. Cell Tissue Bank 2000; 1: 105-109.
4. Jahangir AA, Nunley RM, Mehta S, Sharan AD,. Bone-graft substitutes in orthopaedic surgery. AAOS Now 2008; 2 (1): 35-37.
5. Le Guéhennec L, Layrolle P, Daculsi G,. A review of bioceramics and fibrin sealant. Eur Cell Mater 2004; 8: 1-10.
6. Buser D, Hoffman B, Bernard JP, Lussi A, Mettler D, Shenk RK,. Evaluation of filling materials in membrane protected bone defects-a comparative histomorphometric study in the mandible of miniature pigs. Clin Oral Implant Res 1998; 9: 137-150.
7. Tadic D, Epple M,. A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone. Biomaterials 2004; 25: 987-994.
8. Rokn AR, Moslemi N, Eslami B, Khandagh Abadi H, Paknejad M,. Histologic evaluation of bone healing following application of anorganic bovine bone and β-tricalcium phosphate in rabbit calvaria. J Dent 2012; 9: 35-40.
9. Wahl DA, Czernuszka JT,. Collagen-hydroxyapatite composites for hard tissue repair. Eur Cell Mater 2006; 11: 43-56.
10. Knabe C, Ducheyne P,. Cellular response to bioactive ceramics. In:, Kokutbo T, editor. Bioceramics and their Clinical Applications, in Biomaterials Series No. 9. Cambridge: Woodhead Publishing Limited; 2008. pp. 133-164.
11. Peters F, Reif D,. Functional materials for bone regeneration from beta-tricalcium phosphate. Mat.-wiss.u.Werkstofftech. 2004; 35: 203-207.
12. Kwon B, Jenis LG,. Carrier materials for spinal fusion. Spine J 2005; 5: 224S-230S.
13. Liu B, Lun DX,. Current application of beta-tricalcium phosphate composites in orthopaedics. Orthop Surg 2012; 4: 139-144.
14. Postlethwaite AE, Seyer JM, Kang AH,. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978; 75: 871-875.
15. Rothamel D, Schwarz F, Sager M, Herten M, Sculean A, Becker J,. Biodegradation of differently cross-linked collagen membranes: an experimental study in the rat. Clin Oral Implants Res 2005; 16: 369-378.
16. Schwarz F, Rothamel D, Herten M, Sager M, Becker J,. Angiogenesis pattern of native and cross-linked collagen membranes: an immunohistochemical study in the rat. Clin Oral Implants Res 2006; 17: 403-409.
17. Castellani C, Zanoni G, Tangl S, van GM, Redl H,. Biphasic calcium phosphate ceramics in small bone defects: potential influence of carrier substances and bone marrow on bone regeneration. Clin Oral Implants Res 2009; 20: 1367-1374.
18. Blair HC, Schlesinger PH, Huang CL, Zaidi M,. Calcium signalling and calcium transport in bone disease. Subcell Biochem 2007; 45: 539-562.
19. Blair HC, Robinson LJ, Huang CL, Sun L, Friedman PA, Schlesinger PH, Zaidi M,. Calcium and bone disease. Biofactors 2011; 37: 159-167.
20. Zayzafoon M,. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 2006; 97: 56-70.
21. Ghanaati S, Unger RE, Webber MJ, Barbec M, Orth C, Kirkpatrick JA, Booms P, Motta A, Migliaresi C, Sader RA, Kirkpatrick CJ,. Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells. Biomaterials 2011; 32: 8150-8160.
22. Ghanaati S, Barbeck M, Detsch R, Deisinger U, Hilbig U, Rausch V, Sader R, Unger RE, Ziegler G, Kirkpatrick CJ,. The chemical composition of synthetic bone substitutes influences tissue reactions in vivo: histological and histomorphometrical analysis of the cellular inflammatory response to hydroxyapatite, beta-tricalcium phosphate and biphasic calcium phosphate ceramics. Biomed Mater 2012; 7: 015005 (14 pp).
23. Alvis M, Lalor P, Brown MK, Thorn MR, Block JE, Hornby S, Berg R, Reddi AH,. Osteoinduction by a collagen mineral composite combined with isologous bone marrow in a subcutaneous rat model. Orthopedics 2003; 26: 77-80.
24. Araujo MG, Linder E, Lindhe J,. Bio-Oss collagen in the buccal gap at immediate implants: a 6-month study in the dog. Clin Oral Implants Res 2011; 22: 1-8.
25. ® in a rat critical-size defect model. Clin Implant Dent Relat Res 2012. doi: 10.1111/j.1708-8208.2012. 00467.
26. Kishimoto M, Kanemaru S, Yamashita M, Nakamura T, Tamura Y, Tamaki H, Omori K, Ito J,. Cranial bone regeneration using a composite scaffold of Beta-tricalcium phosphate, collagen, and autologous bone fragments. Laryngoscope 2006; 116: 212-216.
27. Matsuno T, Nakamura T, Kuremoto K, Notazawa S, Nakahara T, Hashimoto Y, Satoh T, Shimizu Y,. Development of beta-tricalcium phosphate/collagen sponge composite for bone regeneration. Dent Mater J 2006; 25: 138-144.
28. Walsh WR, Vizesi F, Cornwall GB, Bell D, Oliver R, Yu Y,. Posterolateral spinal fusion in a rabbit model using a collagen-mineral composite bone graft substitute. Eur Spine J 2009; 18: 1610-1620.
29. Chapman MW, Bucholz R, Cornell C,. Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg Am 1997; 79: 495-502.
30. Ackermann KL,. Extraction site management using a natural bone mineral containing collagen: rationale and retrospective case study. Int J Periodontics Restorative Dent 2009; 29: 489-497.
31. Carter JD, Swearingen AB, Chaput CD, Rahm MD,. Clinical and radiographic assessment of transforaminal lumbar interbody fusion using HEALOS collagen-hydroxyapatite sponge with autologous bone marrow aspirate. Spine J 2009; 9: 434-438.
32. Epstein NE,. An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate. Spine J 2008; 8: 882-887.
33. Epstein NE,. Beta tricalcium phosphate: observation of use in 100 posterolateral lumbar instrumented fusions. Spine J 2009; 9: 630-638.
34. Epstein NE,. Efficacy of posterior cervical fusions utilizing an artificial bone graft expander, beta tricalcium phosphate. Surg Neurol Int 2011; 2: 15 (6 pp).
35. Ray WZ, Wright NM,. Anterior cervical arthrodesis using an osteoconductive scaffold: the use of beta-tricalcium phosphate with local bone marrow aspirate in over 100 patients. SAS J 2009; 3: 114-117.